Definigen Company
Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.
Investors
Technology:
AgeTech Companies, Organoids
Industry:
Healthcare, Providers
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2012-01-01
Employees Number:
11-50
Funding Status:
N/A
Investors Number:
8
Total Funding:
9025885
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-11-19
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership